Search

Zinc oxide nanoparticle (ZnO NP) is an emerging soil pollutant of industrial origin. The unique physicochemical properties of ZnO NP viz. the bioavailability and subsequent ecotoxicological effects on organisms have made it an ecological concern. Lampito mauritii (Kinberg, 1866) is a common anecic earthworm and is considered as a keystone species of soil ecosystems in India. They are continuously exposed to various environmental toxins during their feeding and other activities. The current study aimed to estimate the immunotoxicological effects of ZnO NP in the coelomocytes, the chief immunoeffector cells of L. mauritii. The results of the study indicated decreased total count, phagocytic activity, antioxidative, and detoxifying potential of the coelomocytes in L. mauritii at 7 and 14 days of exposure. ZnO NP exposure resulted in the generation of oxidative molecules, lipid peroxidation, and DNA damage within coelomocytes. The higher degree of cytotoxicity on ZnO NP exposure was suggestive of immunocompromisation in L. mauritii. An integrated biomarker response (IBR) guided methodology was also utilized in estimating the comprehensive effects of ZnO NP on the health of L. mauritii. The present study would provide useful information on the ZnO NP induced chemical stress in L. mauritii , with the selected endpoints having the potential to function as markers for ZnO NP toxicity. [Display omitted] • ZnO NP shifted density, oxidative and detoxifying status of coelomocytes. • High ROS generation, lipid peroxidation and DNA damage by ZnO NP • ZnO NP inhibited phagocytosis of latex beads. • IBR index indicated higher ZnO NP toxicity in long span exposure. [ABSTRACT FROM AUTHOR]

Glioblastoma (GBM) is the most common and the most malignant primary brain tumor in adults, accounting for ∼12-15% of all intracranial neoplasms. Despite advances in surgical, medical and radiation therapies, the mortality of GBM remains high, with a median survival ranging between 40 and 70 weeks. Similar to other primary brain tumors, the extracranial metastasis of GBM is extremely rare, occurring in <2% of patients. To demonstrate the clinical characteristics of this rare tumor, we herein present three cases of extracranial GBM metastasis: One to the lungs, which represents the longest reported survival of lung metastases from GBM to date; the second to the soft tissue of the posterior neck; and the third to the lumbar intradural space. Unlike tumors elsewhere, there are unique barriers in the brain that prevent the hematogenous and lymphatic spread of intracranial tumors, such as the dura mater and the thickened basement membrane of the blood vessels. In addition, central nervous system tumor cells lack extracellular matrix proteins required to invade surrounding connective tissue, a prerequisite for tumor dissemination. In this study, we aimed to investigate the different possible mechanisms underlying the extracranial metastasis of GBM and determine the biomolecular and genetic characteristics differentiating GBMs that metastasize from those that do not. We also reviewed the role of systemic chemotherapy and bevacizumab in the treatment of disseminated GBMs. Early identification and differentiation of these tumors may enable patients to benefit from surgical resection, radiation and combination chemotherapy prior to developing other comorbidities from metastatic disease, which may translate into prolonged survival with an acceptable quality of life. [ABSTRACT FROM AUTHOR]

A middle-aged patient presented for elective embolization of an incidentally found right internal carotid aneurysm. An angiogram was performed, during which the left internal carotid artery was visualized to evaluate a second, small aneurysm. During the embolization of the right internal carotid artery aneurysm, a catheter-induced vasospasm was identified that prompted treatment with intra-arterial verapamil. The procedure was uncomplicated; a postoperative rotational flat-panel computed tomography scan was performed on the angiography table that demonstrated right hemisphere contrast staining. The patient developed a right middle cerebral artery (MCA) syndrome after extubation with repeat cerebral angiography negative for occlusion and magnetic resonance imaging negative for stroke. The patient was observed for 48 hours, during which time the patient had slowly improved. At a six-week follow up visit, the patient had fully recovered. We present an interesting case of a verapamil-induced breakdown of the blood–brain barrier and self-limited right MCA syndrome. [ABSTRACT FROM AUTHOR]

Background  En plaque meningiomas are a rare subtype of meningiomas that are frequently encountered in the spheno-orbital region. Characterized by a hyperostotic and dural invasive architecture, these tumors present unique diagnostic and treatment considerations. Objective  The authors conduct a narrative literature review of clinical reports of en plaque meningiomas to summarize the epidemiology, clinical presentation, diagnostic criteria, and treatment considerations in treating en plaque meningiomas. Additionally, the authors present a case from their own experience to illustrate its complexity and unique features. Methods  A literature search was conducted using the MEDLINE database using the following terminology in various combinations: meningioma , meningeal neoplasms, en plaque , skull base , spheno-orbital, and sphenoid wing. Only literature published in English between 1938 and 2018 was reviewed. All case series were specifically reviewed for sufficient data on treatment outcomes, and all literature was analyzed for reports of misdiagnosed cases. Conclusion  En plaque meningiomas may present with a variety of symptoms according to their location and degree of bone invasion, requiring a careful diagnostic and treatment approach. While early and aggressive surgical resection is generally accepted as the optimal goal of treatment, these lesions require an individualized approach, with further investigation needed regarding the role of new therapies. [ABSTRACT FROM AUTHOR]